Evidence map›Paper›PMID 16612057›Full record

ArticleCommunity genetics2006

How do women decide? Accepting or declining BRCA1/2 testing in a nationwide clinical sample in the United States.

Pamela Sankar, Paul Root Wolpe, Nora L Jones, Mildred Cho

Abstract read
In one paragraph

Article in Community genetics, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Risk information exposure and direct-to-consumer genetic testing for BRCA mutations among women with a personal or family history of breast or ovarian cancer.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2009
    Trial
  2. Review
  3. Online Provision ofCancers · 2024
    Article
  4. Article
  5. Knowledge, Attitudes, Willingness to Pay, and Patient Preferences About Genetic Testing and Subsequent Risk Management for Cancer Prevention.Journal of cancer education : the official journal of the American Association for Cancer Education · 2022
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. What Black Women Know and Want to Know About Counseling and Testing for BRCA1/2.Journal of cancer education : the official journal of the American Association for Cancer Education · 2015
    Article
  12. Exploring the views of parents regarding dietary habits of their young cancer-surviving children.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2015
    Article
  13. Article
  14. Article
  15. Article
  16. Underutilization of BRCA1/2 testing to guide breast cancer treatment: black and Hispanic women particularly at risk.Genetics in medicine : official journal of the American College of Medical Genetics · 2011
    Article
  17. Article
  18. What is in a cause? Exploring the relationship between genetic cause and felt stigma.Genetics in medicine : official journal of the American College of Medical Genetics · 2006
    Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Pamela SankarCenter for Bioethics, University of Pennsylvania, Philadelphia, PA 19104, USA. sankarp@mail.med.upenn.edu
Paul Root Wolpe
Nora L Jones
Mildred Cho

Funding

BRCA1/2 TESTING--PATIENT UPTAKE AND TREATMENT CHOICESR01HG001576 · NHGRI · UNIVERSITY OF PENNSYLVANIA · PI CHO, MILDRED K. · 1997 to 1999
–
NHGRI NIH HHS R01 HG001576NHGRI NIH HHS R01 HG01576
6 · The paper itself

Abstract

objectiveTo examine the role of the practitioner, informed consent, and genetic counseling in genetic testing decisions and to assess their relative influence on women's decision to have clinical BRCA1/2 testing.

methodsQualitative study using in-depth open-ended interviews with 68 women who had considered clinical BRCA1/2 testing.

resultsSlightly less than half of the women who had considered BRCA1/2 testing were found to have had a clear and preexisting desire to test or not to test, irrespective of practitioner attitude or advice.

conclusionThe decision to accept or decline genetic testing is the result of a complex process that goes beyond interactions between health care providers and patients, indicating a caution against exclusive reliance on informed consent or counseling encounters.

Indexed as

Decision MakingGenes, BRCA1Genes, BRCA2AdultAgedBreast NeoplasmsFemaleGenetic TestingHumansInterviews as TopicMiddle AgedUnited States

Identifiers

PMID16612057
PMCPMC1317096

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.